Show simple item record

dc.contributor.authorMaitai, CK
dc.date.accessioned2015-06-21T08:53:52Z
dc.date.available2015-06-21T08:53:52Z
dc.date.issued2010
dc.identifier.citationEast and Central Africa Journal of Pharmaceutical Sciences Vol.13 (2010)en_US
dc.identifier.urihttp://hdl.handle.net/11295/85313
dc.description.abstractThe term “parasitic diseases” is used in a restricted sense to refer to those diseases caused by protozoa (malaria, schistosomiasis, leishmaniasis, trypanosomiasis, amoebiasis, giardiasis) and helminths (hookworm, ascaris, filarial, taenia and flukes). It also refers to diseases caused by ectoparasites (body lice, scabies, jigger). Although parasitic diseases are widespread globally, they tend to be prevalent in the African countries particularly those within or close to the tropical rainy forests. Many tropical parasitic diseases are endemic in countries where the population has low purchasing power. Consequently, multinational companies do not invest significantly in research and development (R&D) of drugs to treat these diseases as the expected financial return in minimal. This has given rise to the phrase, “neglected tropical diseases (NTD)”. It is estimated that approximately 1 billion people worldwide suffer from one or more of these NTD. Typical examples include lymphatic filariasis, onchocerciasias, schistosomiasis, trypanosomiasis and leishmaniasis.en_US
dc.language.isoenen_US
dc.titleTropical parasitic diseasesen_US
dc.typeArticleen_US
dc.type.materialen_USen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record